Old Mission Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Old Mission Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,790	Closed	-$1.02M	–	1271
2025 Q4	$1.02M	Buy	+32,790	New	+$808K	0.02%	402
2021 Q3	–	Sell	-27,104	Closed	-$268K	–	1257
2021 Q2	$268K	Buy	+27,104	New	+$287K	0.01%	804
2021 Q1	–	Sell	-53,932	Closed	-$520K	–	889
2020 Q4	$520K	Buy	+53,932	New	+$517K	0.03%	361
2019 Q2	–	Sell	-12,322	Closed	-$193K	–	332
2019 Q1	$193K	Buy	+12,322	New	+$217K	0.03%	177
2016 Q3	–	Sell	-22,181	Closed	-$1.11M	–	410
2016 Q2	$1.11M	Sell	22,181 -177,204	-89%	-$9.43M	0.08%	132
2016 Q1	$10.7M	Buy	199,385 +158,810	+391%	+$9.32M	1.03%	27
2015 Q4	$2.66M	Buy	+40,575	New	+$2.51M	0.33%	58

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Old Mission Capital's TEVA Position: Q1 2026 in Review

Old Mission Capital sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 32,790 shares — an estimated $1.02M sold.

Old Mission Capital first reported a position in TEVA in Q4 2015 and held it in 7 quarters. The position peaked at $10.7M in Q1 2016. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Old Mission Capital reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Old Mission Capital sold 32,790 Teva Pharmaceuticals shares in Q1 2026, an estimated $1.02M.
Old Mission Capital first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 7 quarters.
Old Mission Capital's Teva Pharmaceuticals position peaked at $10.7M in Q1 2016.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Old Mission Capital's 13F filing for Q1 2026, filed 15 May 2026.